Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 801,393 ordinary shares
- Purchase Date: May 28, 2025
- Highest Price Paid: 417.50 pence per share
- Lowest Price Paid: 413.70 pence per share
- Volume Weighted Average Price: 414.93 pence per share
- Post-Transaction Share Capital: 9,006,925,287 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,002,845,082
Material Changes
The primary material change is the reduction of the Company's share count due to the cancellation of 801,393 shares purchased on May 28, 2025. This transaction updates the total number of ordinary shares with voting rights to 9,002,845,082.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation (Article 5(1)(b)).
Investor Verification Checklist
- Verify the total number of shares purchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price of Haleon shares relative to the 414.93 pence average purchase price.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on the remaining authorization for the share buyback programme.